Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial

BACKGROUND: Although the generic drug approval process has a long-term successful track record, concerns remain for approval of narrow therapeutic index generic immunosuppressants, such as tacrolimus, in transplant recipients. Several professional transplant societies and publications have generated...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS Med
Auteurs principaux: Alloway, Rita R., Vinks, Alexander A., Fukuda, Tsuyoshi, Mizuno, Tomoyuki, King, Eileen C., Zou, Yuanshu, Jiang, Wenlei, Woodle, E. Steve, Tremblay, Simon, Klawitter, Jelena, Klawitter, Jost, Christians, Uwe
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685573/
https://ncbi.nlm.nih.gov/pubmed/29135993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002428
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires